Korea Xeljanz Post-marketing Surveillance for Juvenile Idiopathic Arthritis
Korea Xeljanz Post-marketing Surveillance for Juvenile Idiopathic Arthritis
Recruiting · NCT05754710 · Registry updated 2026-08-03Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Korea Xeljanz Post-marketing Surveillance for Juvenile Idiopathic Arthritis | Oligoarthritis, Juvenile, Skin and Connective Tissue Diseases, arthritic joint disease, arthropathy, autoimmune disease, connective tissue disorder, immune system disorder, juvenile idiopathic arthritis, musculoskeletal system disorder, polyarticular juvenile idiopathic arthritis, rheumatic disorder | Recruiting | Not stated | 2026-08-03 | NCT05754710 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Pfizer | 431 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Pfizer | Seoul | South Korea | 8 |